This inventor holds 17 USPTO granted patents and 10 published patent applications, plus 9 CIPO patents and 9 EPO patents. Top assignees: Nippon Chemiphar Co., Ltd., Kyushu University. Active years: 2013-2025.
Location History:
- Saitama, JP (2016 - 2018)
- Tokyo, JP (2018 - 2022)
- Misato, JP (2013 - 2024)
Company Filing History:
17 out of 132 
4 out of 454 
Years Active: 2013-2025
Title: Toshiyasu Imai: Innovator in Medicinal Chemistry
Introduction
Toshiyasu Imai is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutics. With a total of 17 patents to his name, Imai's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Imai's latest patents include a medicament for treating cough, which features a compound that acts as a P2X4 receptor antagonist. This invention aims to provide an effective solution for preventing or treating coughs. Another notable patent involves a diazepine derivative that serves as a P2X4 receptor antagonist, showcasing Imai's innovative approach to drug development.
Career Highlights
Throughout his career, Toshiyasu Imai has worked with notable organizations such as Nippon Chemiphar Co., Ltd. and Kyushu University. His experience in these institutions has allowed him to refine his expertise in medicinal chemistry and contribute to groundbreaking research.
Collaborations
Imai has collaborated with esteemed colleagues, including Shogo Sakuma and Kazuhide Inoue. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of medicine.
Conclusion
Toshiyasu Imai's contributions to medicinal chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in therapeutic treatments.